Top ASX 200 Performers in FY25: Gold and Tech Lead the Way

July 02, 2025 12:47 AM AEST | By Team Kalkine Media

Google News:

Top ASX 200 Performers in FY25: Gold and Tech Lead the Way — Image source: Shutterstock

Recent News

OMAN INVESTMENT AUTHORITY REPORTS USD 4.1 BILLION PROFIT FOR 2024, RAN...

Good Game, World's First As-live Global Gaming Reality Show announced

With MCAP, Manufacturers Get a Boost in CO2 Reduction Potential

Bedrock Launches BR Trade Streak with $100,000 Prize Pool, Expanding R...

Highlights

Leading ASX 200 stocks from the gold and tech sectors surged significantly during FY25

Regis Resources and Evolution Mining drove gains amid elevated gold prices

TechnologyOne, Zip Co, and Pro Medicus maintained strong performance through software and health tech growth

ASX 200 component Regis Resources Ltd (ASX:RRL) operates within the gold mining sector and recorded standout performance during the financial year. The company’s share price reflected favorable commodity trends and consistent production activity, despite certain operational challenges. As a constituent of the All ordinaries as well, its position within Australia's broad market basket underlined its consistent market relevance.

Another gold stock, Evolution Mining Ltd (ASX:EVN), also part of the ASX 100, experienced robust momentum. The company’s operational efficiency and sector tailwinds supported its strong equity performance throughout the year. Activities around group-level cash flow and financial liquidity received notable attention from the broader australia share market.

Technology Sector Shows Continued Expansion

Enterprise software provider TechnologyOne Ltd (ASX:TNE), listed in the ASX 200 and ASX 100, gained strong traction during the period. Cloud transformation initiatives and an expanding software-as-a-service footprint contributed to its solid positioning. Business developments and consistent performance over multiple quarters aligned with sector-wide digital growth trends.

Similarly, Zip Co Ltd (ASX:ZIP), also in the All ordinaries, advanced as demand increased for now-pay-later services. Operational activities, especially in the U.S. market, were a core area of interest during the fiscal year. Progress in transaction volumes and user engagement played a role in the upward trend observed in its share movement.

Health Technology Maintains Strong Footing

Pro Medicus Ltd (ASX:PME), featured in both the ASX 200 and ASX 100, is engaged in medical imaging technology. The company expanded its global reach through strategic long-term contracts. These agreements highlighted the broader adoption of imaging platforms across major health networks. Business development across international markets contributed to the company’s gains during the financial year.

ASX Performance Concentrated Around Selective Sectors

The overall FY25 performance saw notable activity in selective ASX sectors, especially those connected with precious metals and software. With key players such as Regis Resources and Evolution Mining showing momentum in gold, and companies like TechnologyOne and Pro Medicus expanding in digital and healthcare technologies, market focus centered around operational efficiency and consistent output. Each of these stocks represents a significant part of Australia's evolving sector-based strength, as reflected within the ASX 200 and All ordinaries.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.